# Multi-Technology Integrated Total Mesorectal Excision Versus Conventional Total Mesorectal Excision for the Treatment of Middle and Distal Rectal Cancer.

> **NCT06613399** · NA · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 324 (estimated)

## Conditions studied

- Rectal Cancer

## Interventions

- **PROCEDURE:** MTI-TME
- **PROCEDURE:** C-TME

## Key facts

- **NCT ID:** NCT06613399
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2026-01-01
- **Final completion:** 2027-12-31
- **Target enrollment:** 324 (ESTIMATED)
- **Last updated:** 2024-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06613399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06613399, "Multi-Technology Integrated Total Mesorectal Excision Versus Conventional Total Mesorectal Excision for the Treatment of Middle and Distal Rectal Cancer.". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT06613399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*